These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1832506)

  • 1. [Neurohumoral and functional determinants of destabilization in patients with acute forms of ischemic heart disease].
    Tashchuk VK; Savitskiĭ SIu; Shumakov VA; Popova LI; Malinovskaia IE; Reĭko MN
    Vrach Delo; 1991 Jun; (6):28-30. PubMed ID: 1832506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
    Ermakovich II; Ladnyĭ AI; Volkov VI; Tseluĭko VI
    Vrach Delo; 1990 Sep; (9):25-8. PubMed ID: 2284757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients].
    Volkov VI; Ladnyĭ AI
    Vrach Delo; 1989 Nov; (11):60-2. PubMed ID: 2514486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prostacyclin-thromboxane A2 system in ischemic heart disease].
    Pavlov NA
    Sov Med; 1987; (2):36-9. PubMed ID: 3554549
    [No Abstract]   [Full Text] [Related]  

  • 5. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia].
    Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP
    Sov Med; 1988; (4):3-6. PubMed ID: 3043710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stenocardia. Thromboxane A2 and prostacyclin].
    Panchenko EP
    Kardiologiia; 1986 Jul; 26(7):109-16. PubMed ID: 3093749
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma fibrinopeptide A and beta-thromboglobulin in major bacterial infections.
    van Hulsteijn H; Fibbe W; Bertina R; Briët E
    Thromb Haemost; 1982 Dec; 48(3):247-9. PubMed ID: 6187081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet hyperactivity in acute myocardial infarction in man--effects of prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Herz; 1986 Apr; 11(2):116-26. PubMed ID: 2939012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet reactivity in unstable coronary artery disease.
    Swahn E; Wallentin L
    Thromb Haemost; 1987 Jun; 57(3):302-5. PubMed ID: 2958954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboxane and prostacyclin in disease: a review.
    Halushka PV; Dollery CT; MacDermot J
    Q J Med; 1983; 52(208):461-70. PubMed ID: 6361838
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
    Al-Mondhiry H; Pierce WS; Pennock JL
    J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The functional state of the myocardium during transesophageal electrocardiostimulation in patients with ischemic heart disease].
    Furkalo NK; Lomakovskiĭ AN
    Vrach Delo; 1991 Oct; (10):40-3. PubMed ID: 1803743
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists].
    Dzgoeva FU; Kutyrina IM
    Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Redistribution of the coronary blood flow, functional improvement of the ischemic myocardium and reduction of the size of an experimental infarction by molsidomine].
    Berdeaux A; Giudicelli JF
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):511-5. PubMed ID: 6364947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The release of thromboxane A2 and prostacyclin due to vasoactive agents in hypercholesterolemic rabbits].
    Takahashi K
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):737-44. PubMed ID: 3096856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
    Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
    Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac release of prostacyclin and thromboxane A2 during coronary revascularization.
    Teoh KH; Fremes SE; Weisel RD; Christakis GT; Teasdale SJ; Madonik MM; Ivanov J; Mee AV; Wong PY
    J Thorac Cardiovasc Surg; 1987 Jan; 93(1):120-6. PubMed ID: 3540456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelets and myocardial ischemia].
    Zhao ZQ; Zang YM
    Sheng Li Ke Xue Jin Zhan; 1989 Jan; 20(1):36-9. PubMed ID: 2672308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.